Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
SPOP mutations as a Predictive Biomarker for Androgen Receptor-Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate CancerClin. Cancer Res 2022 Sep 11;[EPub Ahead of Print], U Swami, RP Graf, RH Nussenzveig, V Fisher, H Tukachinsky, AB Schrock, G Li, JS Ross, N Sayegh, N Tripathi, V Mathew Thomas, GR Oxnard, ES Antonarakis, N Agarwal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.